Feedback / Questions
lirentelimab (AK002) - Allakos
Xolair (omalizumab) - Roche, Novartis
http://www.ncbi.nlm.nih.gov/pubmed/33391286
Jan 5, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next